Peyronie's disease (PD) is a superficial fibrosing disorder of the penis resulting in plaque
formation and penile deformity. Once considered rare, PD has more recently been found in …

Introduction: Peyronie's disease (PD) is a wound-healing disorder of the tunica albuginea of
the penis which affects 3–9% of adult males. Clinically, any combination of plaque formation …

Peyronie's disease (PD) is known to be associated with Dupuytren's disease (DD) since
1828. The aim of this study was to investigate the coexistence of DD in a consecutive series …

The medical treatment is indicated in the development stage of Peyronie's disease (PD) for
at least 1 year after diagnosis and whenever in case of penile pain. This research was …

Peyronie's disease is a fibrotic disorder of the tunica albuginea of the penis resulting in
varying degrees of penile curvature and sexual dysfunction. Diagnosis of the disorder is …

Peyronie's disease (PD) is a connective tissue disorder characterized by a fibrous plaque
involving the tunica albuginea of the penis. The inelastic fibrous plaque leads to a penile …

Non-surgical treatment of Peyronie's disease (PD) has come a long way since it was first
described in 1743. A myriad of treatment options are currently available, including oral …

The comorbid conditions erectile dysfunction (ED) and depression are both highly prevalent
in men. The National Comorbidity Survey found a lifetime prevalence of major depression of …

Potassium para-aminobenzoate (POTABA) is used to treat Peyronie's disease by
decreasing fibrosis and plaque size progression. Among potential side effects, drug-induced …

The aim of this article is to analyse the long-term results of different surgical techniques for
correction of penile deviations in Peyronie's disease. Patients who underwent surgery for a …